Randomized Phase 2 Trial of Two Different Doses of Ixazomib in Patients with Relapsed Multiple Myeloma Not Refractory to Bortezomib

Kumar, Shaji K ; Laplant, Betsy R. ; Reeder, Craig B. ; Roy, Vivek ; Buadi, Francis ; Gertz, Morie A. ; Laumann, Kristina ; Bergsagel, Peter Leif ; Dispenzieri, Angela ; Kapoor, Prashant ; Mikhael, Joseph ; Stewart, Keith ; Hayman, Suzanne R. ; Hwa, Yi L. ; Witzig, Thomas E. ; Ailawadhi, Sikander ; Dingli, David ; Go, Ronald S. ; Lin, Yi ; Rivera, Candido E. ; Rajkumar, S. Vincent ; Lacy, Martha Q.

Blood, 2015-12, Vol.126 (23), p.3050-3050 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível